Comparison of dose enhancement effect of iron oxide nanoparticles on HeLa cancerous cell line exposed to high-energy electron and photon beams

Authors
Karim khoshgard 1
Hossein mafakheri 1
Ahmad Mohammadbeigi 1
Maryam hazbavi 2
Masoud Rezaei 1
1 Kermanshah University of Medical Sciences
2 Ahvaz Jundishapur University of Medical Sciences
Abstract
Introduction and aims: The aim of radiotherapy is delivering lethal dose of radiation to tumor cells while adjacent healthy tissues would have the least amount of irradiation. One way to increase the dose in the tumor cells is using high atomic number nanoparticles as radiation sensitizers in these cells.

Materials and Methods: Dextran-coated iron oxide nanoparticles at different concentrations (10, 40 and 80 µg/ml) were incubated with HeLa cell line of cervical cancer for 24 hours and then the cells irradiated with different doses (0, 2, 4, 6 and 8 Gy) of 6 MeV electron and 6 MV photon beams. Survival fraction of the cells was evaluated by MTT assay.

Results: The survival fraction in the groups receiving radiation in the absence and presence of iron oxide nanoparticles showed significant differences (p<0.05). The average of dose enhancement factors in 10, 40 and 80 µg/ml concentrations with 6 MeV irradiations obtained 1.13± 0.04, 1.19± 0.05 and 1.25±0.07, respectively; and with 6 MV photon irradiations these factors obtained 1.19± 0.15 and 1.49± 0.11 in 10 and 40 µg/ml, respectively.

Conclusion: Using iron oxide nanoparticles coated with dextran can increase the absorbed dose and consequently cell killing in cervical cancer cells (HeLa).
Keywords
Radiotherapy
Radiation-Sensitizing Agents
Nanoparticles
Iron Oxide
cervical cancer
Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA oncology 2017; 3(4):524-48.
Uzan J, Nahum AE, Syndikus I. Prostate dose-painting radiotherapy and radiobiological guided optimisation enhances the therapeutic ratio. Clin Oncol (R Coll Radiol) 2016; 28(3):165-70.
Babaei M, Ganjalikhani M. The potential effectiveness of nanoparticles as radio sensitizers for radiotherapy. BioImpacts: BI 2014; 4(1):15.
McQuaid HN, Muir MF, Taggart LE, McMahon SJ, Coulter JA, Hyland WB, et al. Imaging and radiation effects of gold nanoparticles in tumour cells. Sci Rep 2016; 6:19442.
Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011; 63(3):136-51.
Sharma V, Shukla RK, Saxena N, Parmar D, Das M, Dhawan A. DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Toxicol Lett 2009; 185(3):211-8.
Ren F, Bhana S, Norman DD, Johnson J, Xu L, Baker DL, et al. Gold nanorods carrying paclitaxel for photothermal-chemotherapy of cancer. Bioconjug Chem 2013;24(3):376-86.
Sharma H, Mishra PK, Talegaonkar S, Vaidya B. Metal nanoparticles: a theranostic nanotool against cancer. Drug Discov Today 2015;20(9):1143-51.
Kong T, Zeng J, Wang X, Yang X, Yang J, McQuarrie S, et al. Enhancement of Radiation Cytotoxicity in Breast‐Cancer Cells by Localized Attachment of Gold Nanoparticles. small 2008;4(9):1537-43.
Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 2004;49(18):N309.
Khoshgard K, Hashemi B, Arbabi A, Rasaee MJ, Soleimani M. Radiosensitization effect of folate-conjugated gold nanoparticles on HeLa cancer cells under orthovoltage superficial radiotherapy techniques. Phys Med Biol 2014;59(9):2249.
Rahman WN, Bishara N, Ackerly T, He CF, Jackson P, Wong C, et al. Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomedicine: Nanotechnology, Biology and Medicine. 2009;5(2):136-42.
Jain S, Coulter JA, Hounsell AR, Butterworth KT, McMahon SJ, Hyland WB, et al. Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. International Journal of Radiation Oncology* Biology* Physics 2011;79(2):531-9.
Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev 2011;63(1):24-46.
Khoei S, Mahdavi SR, Fakhimikabir H, Shakeri-Zadeh A, Hashemian A. The role of iron oxide nanoparticles in the radiosensitization of human prostate carcinoma cell line DU145 at megavoltage radiation energies. Int J Radiat Biol 2014;90(5):351-6.
Tomić S, Đokić J, Vasilijić S, Ogrinc N, Rudolf R, Pelicon P, et al. Size-dependent effects of gold nanoparticles uptake on maturation and antitumor functions of human dendritic cells in vitro. PloS one 2014;9(5):e96584.
Chen LQ, Fang L, Ling J, Ding CZ, Kang B, Huang CZ. Nanotoxicity of silver nanoparticles to red blood cells: size dependent adsorption, uptake, and hemolytic activity. Chem Res Toxicol 2015;28(3):501-9.
Briggs A, Corde S, Oktaria S, Brown R, Rosenfeld A, Lerch M, et al. Cerium oxide nanoparticles: influence of the high-Z component revealed on radioresistant 9L cell survival under X-ray irradiation. Nanomedicine: Nanotechnology, Biology and Medicine 2013;9(7):1098-105.
Roa W, Zhang X, Guo L, Shaw A, Hu X, Xiong Y, et al. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology 2009;20(37):375101.
Liu C-J, Wang C-H, Chen S-T, Chen H-H, Leng W-H, Chien C-C, et al. Enhancement of cell radiation sensitivity by pegylated gold nanoparticles. Phys Med Biol 2010;55(4):931.